New hope for tough ovarian cancer: first human trial of MEN2501 launches
NCT ID NCT07226427
First seen Jun 27, 2026 · Last updated Jul 07, 2026 · Updated 2 times
Summary
This early-stage trial tests a new drug called MEN2501 in about 100 adults with ovarian cancer that has stopped responding to platinum chemotherapy. The main goals are to check safety and find the best dose. Researchers will also watch for signs that the drug shrinks tumors or slows the cancer.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FALLOPIAN TUBE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cancer Research SA
RECRUITINGAberfoyle Park, 5000, Australia
-
Clínica Universidad Navarra
RECRUITINGMadrid, 28027, Spain
-
Clínica Universidad de Navarra
RECRUITINGPamplona, 31008, Spain
-
Florida Cancer Specialists & Research Institute
RECRUITINGSarasota, Florida, 34232, United States
-
Highlands Oncology Group
RECRUITINGSpringdale, Arkansas, 72762, United States
-
Hospital Quironsalud Madrid
RECRUITINGPozuelo de Alarcón, 28226, Spain
-
Hospital Universitario 12 de Octubre
RECRUITINGMadrid, 28041, Spain
-
Hospital Universitario Dexeus - Grupo Quironsalud
RECRUITINGBarcelona, 08028, Spain
-
Hospital Universitario HM Sanchinarro
RECRUITINGMadrid, 28050, Spain
-
Icon Cancer Centre
RECRUITINGSouth Brisbane, Queensland, 4101, Australia
-
Karmanos Cancer Institute
RECRUITINGDetroit, Michigan, 48201, United States
-
Massachusetts General Hospital
RECRUITINGBoston, Massachusetts, 02114, United States
-
Mayo Clinic
RECRUITINGRochester, Minnesota, 55905, United States
-
NEXT Virginia
RECRUITINGFairfax, Virginia, 22031, United States
-
Yale University
RECRUITINGNew Haven, Connecticut, 06519, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a custom vaccine train the body to fight ovarian cancer?
- Can a 'Smart Bomb' drug outsmart recurrent ovarian cancer?
- Can a targeted drug boost standard ovarian cancer therapy?
- Can heated chemo during surgery help older women with ovarian cancer?
- Can a daily pill keep BRCA-Linked ovarian cancer at bay?
- New drug cocktail aims to shrink recurrent ovarian tumors